Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 3, 1999, Pages 505-510

  George, Jacob ^a   Shoenfeld, Yehuda ^a,c   Afek, Arnon ^a   Gilburd, Boris ^a   Keren, Pnina ^a   Shaish, Aviv ^a   Kopolovic, Juri ^a   Wick, Georg ^b   Harats, Dror ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Atherosclerosis; Autoantibodies; Heat shock protein 65; Mycobacterium tuberculosis; Oxidized LDL

Indexed keywords

BUFFER; CD4 ANTIGEN; HEAT SHOCK PROTEIN 65; IMMUNOGLOBULIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATE; RECOMBINANT PROTEIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA SINUS; ARTICLE; ATHEROGENESIS; CELLULAR IMMUNITY; CHOLESTEROL DIET; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN DEPOSITION; LYMPHOCYTIC INFILTRATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0032976306     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.3.505     Document Type: Article

References (32)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 1991;64:5-15.
3. van der Wal AC. Atherosclerotic lesions in humans: in situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest. 1989;61:166-170.
4. Steinberg D, Witztum JL. Lipoproteins and atherogenesis: current concepts. JAMA. 1990;264:3047-3052.
5. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q. Is atherosclerosis an immunologically mediated disease? Immunol Today. 1995;16:27-33.
6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modification of low density lipoprotein that increases its atherogenicity. N Engl J Med. 1989;320:915-924.
7. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994; 344:793-795.
8. Xu Q, Wick G. The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol Med Today. 1996;2:372-379.
9. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989;86:1372-1376.
10. Yla-Herttuala S, Palinski W, Butler SW, Picard W, Steinberg W, Witztum JL. Rabbit and human atherosclerotic lesion contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb. 1994;14:32-40.
11. Stemme S, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1995;92:3893-3897.
12. Palinski W, Miller E, Witztum JL. Immunization of low density lipoprotein (LDL) deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci U S A. 1995; 92:821-825.
13. Ameli SA, Hultgardh-Nilsson, Regnstrom J, Calara F, Yana J, Cercek B, Shah PK, Nilsson J. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol. 1996;16:1074-1079.
14. Nilsson J, Calara F, Regnstrom J, Hultgardh-Nilsson A, Ameli S, Cercek B, Shah PK. Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon angioplasty in hypercholesterolemic rabbits. J Am Coll Cardiol. 1997;30:1886-1891.
15. George J, Afek A, Gilburd B, Levkovitz H, Shaish A, Goldberg I, Kopolovic J, Wick G, Shoenfeld Y, Harats D. Hyperimmunization of apoE deficient mice with homologous MDA-low density lipoprotein suppresses early atherogenesis. Atherosclerosis. 1998;138:147-152.
16. Xu Q, Dietrich H, Steiner HJ, Gown AM, Schoel B, Mikuz G, Kaufman SHE, Wick G. Induction of arteriosclerosis in normocholesterolemic mice and rabbits by immunization with heat shock protein 65. Arterioscler Thromb. 1992;12:789-799.
17. Xu Q, Kleindienst R, Waitz H, Dietrich H, Wick G. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J Clin Invest. 1993;91:2693-2702.
18. Xu Q, Willeit J, Marosi M, Kleindienst R, Oberhollenzer F, Kiechl S, Stulnig T, Luef G, Wick G. Association of serum antibodies to heat shock protein 65 with carotid atherosclerosis. Lancet. 1993;341:255-259.
19. Hoppichler F, Lechleitner M, Traweger C, Schett G, Dzien A, Sturm W, Xu Q. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis. 1996;126: 333-338.
20. George J, Blank M, Hojnik M, Bar-Meir E, Koike T, Matsuura E, Lorber M, Aviram M, Shoenfeld Y. Oxidized low density lipoprotein (oxLDL) but not LDL aggravates the manifestations of antiphospholipid syndrome (APS). Clin Exp Immunol. 1997;108:227-233.
21. Elias D, Markovits D, Reshef T, van der Zee R, Cohen IR. Induction and therapy in non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci U S A. 1990;87:1576-1580.
22. Qiao JH, Xie PZ, Fishbein MC, Kreuzer J, Drake TA, Demer LL, Lusis AJ. Pathology of atheromatous lesions in inbred and genetically engineered mice: genetic determinations of arterial calcification. Arterioscler Thromb. 1994;14:1480-1497.
23. Palinski W, Yla-Herttuala S, Rosenfeld ME, Butler S, Socher SA, Parthasarathy S, Curtiss LK, Witztum JL. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 1990;10:325-335.
24. Cook PJ, Lip GYH. Infectious agents and atherosclerotic vascular disease. Q J Med. 1996;89:727-735.
25. Schett G, Xu Q, Amberger A, Van der Zee R, Recheis H, Willeit J, Wick G. Antibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest. 1995;96:2569-2577.
26. Emeson EE, Shen ML. Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporine A. Am J Pathol. 1993;142: 1906-1915.
27. Roselaar SE, Schonfeld G, Daugherty A. Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. J Clin Invest. 1995;96:1389-1394.
28. Emeson EE, Shen ML, Bell CGH, Qureshi A. Inhibition of atherosclerosis in CD4 T-cell ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice. Am J Pathol. 1996;149:675-685.
29. Dansky HM, Charlton SA, Harper MM, Smith JD. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A. 1997;94:4642-4646.
30. Daugherty A, Pure E, Delfel-Butteiger D, Chen S, Leferovich J, Roselaar SE, Rader DJ. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/-mice. J Clin Invest. 1997;100: 1575-1580.
31. Capron L. Chlamydia in coronary plaques: hidden culprits or harmless hobo? Nat Med. 1996;8:856-857.
32. Hajjar DP, Pomerantz KB, Falcone DJ, Weksler BB, Grant AJ. Herpes simplex virus infection in human arterial cells: implications in atherosclerosis. J Clin Invest. 1987;80:1317-1321.